HCAT
HCAT
NASDAQ · Health Care

Health Catalyst Inc

$1.99
+0.03 (+1.53%)
Financial Highlights (FY 2026)
Revenue
328.07M
Net Income
-187,661,184
Gross Margin
49.7%
Profit Margin
-57.2%
Rev Growth
+4.1%
D/E Ratio
0.62
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 49.7% 49.7% 29.0% 29.0%
Operating Margin -51.7% -46.5% 12.9% 14.1%
Profit Margin -57.2% -54.3% 10.8% 12.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 328.07M 315.30M 32.58M 30.28M
Gross Profit 163.05M 156.70M 9.46M 8.79M
Operating Income -169,610,231 -146,707,552 4.21M 4.28M
Net Income -187,661,184 -162,321,062 3.53M 3.69M
Gross Margin 49.7% 49.7% 29.0% 29.0%
Operating Margin -51.7% -46.5% 12.9% 14.1%
Profit Margin -57.2% -54.3% 10.8% 12.2%
Rev Growth +4.1% +4.1% +12.6% +17.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 26.89M 26.89M 50.32M 42.45M
Total Equity 43.13M 43.13M 108.46M 121.60M
D/E Ratio 0.62 0.62 0.46 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -116,356,862 -106,236,442 6.92M 5.56M
Free Cash Flow 3.08M 3.74M